# Appvance

> Appvance is a Santa Clara software company whose AIQ platform generates, executes and reports tests for enterprise web, mobile, desktop and API applications. Its distinctive bet is that an application model and AI-generated exploration can uncover useful user journeys beyond those a tester writes in advance. GENI adds conversion of written test cases into executable scripts. The company sells to enterprise QA, development and DevOps teams through per-application commercial arrangements and partners.

- **Founded:** 2012
- **Headquarters:** Santa Clara, United States
- **Founders:** Kevin Surace (Co-founder; CEO and CTO), Frank Cohen (Founder; original test automation entrepreneur)
- **Products:** Appvance IQ (AIQ), AIQ 5.2.0, GENI, GENI Transformation Factory, AI ASSERT
- **Notable:** A 2023 company case study reported more than 95% application coverage across eight applications at an auto-parts supplier, compared with earlier manual tests that reached about 15% code coverage., A 2023 health-agency case study reported more than 3,000 unique application flows after a week of training, plus more than 200 human-written scripts for mandated cases., A 2023 insurer case study reported 97% code coverage and a reduction in mean time to error resolution from days to hours.

## Products & services

- **Appvance IQ (AIQ)** — Unified software quality platform for autonomous test generation, functional, API, performance, load and security testing, execution and reporting.
- **AIQ 5.2.0** — Release adding coverage maps, visual accessors, Desktop Designer and expanded API Designer with Postman conversion.
- **GENI** — Converts natural-language test cases into executable scripts using the AIQ application model; announced with per-application availability.
- **GENI Transformation Factory** — Transforms QA artifacts in both directions, from requirements to scripts and scripts back to higher-level descriptions, with MCP-compatible model choice.
- **AI ASSERT** — Natural-language validation of visual, motion and text outcomes in the Web Designer module.

## Achievements

- A 2023 company case study reported more than 95% application coverage across eight applications at an auto-parts supplier, compared with earlier manual tests that reached about 15% code coverage.
- A 2023 health-agency case study reported more than 3,000 unique application flows after a week of training, plus more than 200 human-written scripts for mandated cases.
- A 2023 insurer case study reported 97% code coverage and a reduction in mean time to error resolution from days to hours.
- The company announced U.S. Patent No. 12,353,317 in July 2025 for generating test scripts and updating an application model.

## Latest updates

- **2026-05** — Appointed Aimee Senour vice president of sales.
- **2025-10** — Added AI ASSERT for natural-language validation of visual and behavioral UI outcomes.
- **2025-10** — Added generation of API scripts and synthetic test data from OpenAPI specifications.
- **2025-09** — Announced GENI Transformation Factory with MCP support and bidirectional QA artifact generation.

## Links

- Website: https://appvance.ai
- LinkedIn: https://www.linkedin.com/company/appvance
- Twitter/X: https://twitter.com/appvance
- Facebook: https://www.facebook.com/AppvanceInc/

---

Profile page: https://yespress.io/appvance
Published by YesPress — https://yespress.io
Last updated: 2026-09-29